La marque AEGEAN - Assessment of an Education and Guidance program for Eliquis Adherence in Non-valvular atrial fibrillation, fondée en 2012 (États-Unis), a 496 marques sœurs et 17477 marques concurrentes. AEGEAN - Assessment of an Education and Guidance program for Eliquis Adherence in Non-valvular atrial fibrillation est une marque de la société BRISTOL-MYERS SQUIBB COMPANY, cotée à la bourse de New York. AEGEAN - Assessment of an Education and Guidance program for Eliquis Adherence in Non-valvular atrial fibrillation appartient au secteur d’activité Fabricants de médicaments.
L'actualité de la marque AEGEAN - Assessment of an Education and Guidance program for Eliquis Adherence in Non-valvular atrial fibrillation
Derniers Tweets
BRISTOL-MYERS SQUIBB COMPANY
(AEGEAN - Assessment of an Education and Guidance program for Eliquis Adherence in Non-valvular atrial fibrillation)
.
Toute l'actualité 
BRISTOL-MYERS SQUIBB COMPANY
(AEGEAN - Assessment of an Education and Guidance program for Eliquis Adherence in Non-valvular atrial fibrillation)
Derniers Tweets
BRISTOL-MYERS SQUIBB COMPANY
(AEGEAN - Assessment of an Education and Guidance program for Eliquis Adherence in Non-valvular atrial fibrillation)
.
